Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7SAN

Crystal structure of human hypoxanthine guanine phosphoribzosyltransferase in complex with (4S,7S)-7-hydroxy-4-((guanin-9-yl)methyl)-2,5-dioxaheptan-1,7-diphosphonate

Summary for 7SAN
Entry DOI10.2210/pdb7san/pdb
DescriptorHypoxanthine-guanine phosphoribosyltransferase, ({(2S)-3-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-2-[(2S)-2-hydroxy-2-phosphonoethoxy]propoxy}methyl)phosphonic acid (3 entities in total)
Functional Keywordsinhibitor, complex, phosphonate, purine, transferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceHomo sapiens (human)
Total number of polymer chains4
Total formula weight99313.06
Authors
Guddat, L.W.,Keough, D.T. (deposition date: 2021-09-22, release date: 2022-05-18, Last modification date: 2023-10-18)
Primary citationKlejch, T.,Keough, D.T.,King, G.,Dolezelova, E.,Cesnek, M.,Budesinsky, M.,Zikova, A.,Janeba, Z.,Guddat, L.W.,Hockova, D.
Stereo-Defined Acyclic Nucleoside Phosphonates are Selective and Potent Inhibitors of Parasite 6-Oxopurine Phosphoribosyltransferases.
J.Med.Chem., 65:4030-4057, 2022
Cited by
PubMed Abstract: Pathogens such as and spp. are unable to synthesize purine nucleobases. They rely on the salvage of these purines and their nucleosides from the host cell to synthesize the purine nucleotides required for DNA/RNA production. The key enzymes in this pathway are purine phosphoribosyltransferases (PRTs). Here, we synthesized 16 novel acyclic nucleoside phosphonates, 12 with a chiral center at C-2', and eight bearing a second chiral center at C-6'. Of these, bisphosphonate (,)- is the most potent inhibitor of the and 6-oxopurine PRTs and the most potent inhibitor of two () 6-oxopurine PRTs yet discovered, with values as low as 2 nM. Crystal structures of (,)- in complex with human and 6-oxopurine PRTs show that the inhibitor binds to the enzymes in different conformations, providing an explanation for its potency and selectivity (, 35-fold in favor of the parasite enzymes).
PubMed: 35175749
DOI: 10.1021/acs.jmedchem.1c01881
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.58155523622 Å)
Structure validation

250835

PDB entries from 2026-03-18

PDB statisticsPDBj update infoContact PDBjnumon